Skip to main content
SpringerLink
Log in

Emergence ofStreptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The aim of this study was to determine the evolution of resistance to macrolides and other antibiotics in strains ofStreptococcus pyogenes isolated in the province of Gipuzkoa, Spain. During the period 1984–1996, all 2561 strains ofStreptococcus pyogenes studied showed full susceptibility to penicillin. Until 1990, only 1.2% ofStreptococcus pyogenes isolates were resistant to erythromycin. Since then, resistance to erythromycin increased every year until 1995, when 34.8% (87/250) ofStreptococcus pyogenes strains were found to be resistant. In 1996 the rate of resistance to erythromycin was 17.8% (75/422). During the study period, 96.1% (246/256) of theStreptococcus pyogenes isolates resistant to erythromycin were susceptible to clindamycin. Of the remaining erythromycin-resistantStreptococcus pyogenes strains, resistance to clindamycin was constitutive in seven strains and inducible in three. When investigated by the polymerase chain reaction (PCR), allStreptococcus pyogenes strains resistant to erythromycin and susceptible to clindamycin showed the 1.4 kb fragment of themefA gene, recently described as the novel macrolide-efflux-resistance determinant. The most frequent T-agglutination patterns amongStreptococcus pyogenes resistant to erythromycin were T4 and T8,25. The emergence and rapid spread of erythromycin-resistantStreptococcus pyogenes in Gipuzkoa and its relationship to the presence of themefA gene are described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bisno A:Streptococcus pyogenes: In: Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1995, p. 1786–1799.

    Google Scholar 

  2. Stingemore N, Francis GJR, Toohey M, McGechie DB: The emergence of erythromycin resistance inStreptococcus pyogenes in Fremantle, Western Australia. Medical Journal of Australia 1989, 150: 626–631.

    Google Scholar 

  3. Holmstrom L, Nyman B, Rosengren M, Wallander S, Ripa T: Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres. Scandinavian Journal of Infectious Diseases 1990, 22: 179–185.

    Google Scholar 

  4. Philipps G, Parratt D, Orange GV, Harper I, McEwan H, Young N: Erythromycin-resistantStreptococcus pyogenes. Journal of Antimicrobial Chemotherapy 1990, 25: 723–724.

    Google Scholar 

  5. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksoon T, Herva E, Holm SE, Jahkola M, Katila ML, Klaukka T, Kontiainen S, Liimatainen O, Olinonen S, Passi-Metsomaa L, Huovinen P: Resistance to erythromycin in group A streptococci. New England Journal of Medicine 1992, 326: 292–297.

    Google Scholar 

  6. Lowbury EJL, Hurst L: The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin and spiramycin. Journal of Clinical Pathology 1959, 12: 163–169.

    Google Scholar 

  7. Dixon JMS, Lipinski AE: Infections with beta-hemolyticStreptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin. Journal of Infectious Diseases 1974, 130: 351–356.

    Google Scholar 

  8. Maruyama S, Yoshioka H, Fujita K, Takimoto M, Satake Y: Sensitivity of group A streptococci to antibiotics: prevalence of resistance to erythromycin in Japan. American Journal of Diseases of Children 1979, 133: 1143–1145.

    Google Scholar 

  9. Sanders E, Foster MT, Scott D: Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. New England Journal of Medicine 1968, 278: 538–540.

    Google Scholar 

  10. Leclercq R, Courvalin P: Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrobial Agents and Chemotherapy 1991, 35: 1273–1276.

    Google Scholar 

  11. Weisblum B: Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression—a review. Journal of Antimicrobial Chemotherapy 1985, 16, Supplement A. 63–90.

    Google Scholar 

  12. Seppala H, Nissinen A, Yu Q, Huovinen P: Three different phenotypes of erythromycin-resistantStreptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy 1993, 32: 885–891.

    Google Scholar 

  13. Sutcliffe J, Tait-Kamradt A, Wondrack L:Streptococcus pneumoniae andStreptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy 1996, 40: 1817–1824.

    Google Scholar 

  14. Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, Retsema JA: Molecular cloning and functional analysis of a novel macrolide-resistance determinant,mefA, formStreptococcus pyogenes. Molecular Microbiology 1996, 22: 867–879.

    Google Scholar 

  15. EUSTAT (Euskal Estatistika-Erakundea—Instituto Vasco de Estadística): Anuario Estadístico Vasco 1995. Habitantes, Movimiento Natural y Migraciones. Gobierno Vasco, Vitoria, Spain, 1996, p. 35–81.

    Google Scholar 

  16. Johnson DR, Kaplan EL, Sramek J, Bicova R, Havlicek J, Havlickova H, Motlova J, Kriz P: Determination of T-protein agglutination paterns. In: Laboratory diagnosis of group A streptococcal infections. World Health Organisation, Geneva, 1996, p. 37–41.

    Google Scholar 

  17. Perez-Trallero E, Garcia-Arenzana JM, Urbieta-Egaña M: Erythromycin resistance in streptococci. Lancet 1989, ii: 444–445.

    Google Scholar 

  18. Istre GR, Welch DF, Marks MI, Moyer N: Susceptibility of group A beta-hemolyticStreptococcus isolates to penicillin and erythromycin. Antimicrobial Agents and Chemotherapy 1981, 20: 244–246.

    Google Scholar 

  19. Zackrisson G, Lind L, Roos K, Larsson P: Erythromycin-resistant beta-hemolytic streptococci group A in Goteborg, Sweden. Scandinavian Journal of Infectious Diseases 1988, 20: 419–420.

    Google Scholar 

  20. Borzani M, Varotto F, Garlaschi L, Conio F, Dell'Olio M, Careddu P: Clinical and microbiological evaluation of miocamycin activity against group A beta-hemolytic streptococci in pediatric patients. Journal of Chemotherapy 1989, 1: 35–38.

    Google Scholar 

  21. Scott RJD, Naidoo J, Lightfoot NF, George RC: A community outbreak of group A beta-haemolytic streptococci with transferable resistance to erythromycin. Epidemiology and Infection 1989, 102: 85–91.

    Google Scholar 

  22. Spencer RC, Wheat PF, Magee JT, Brown EH: Erythromycin resistance in streptococci. Lancet 1989, i: 168.

    Google Scholar 

  23. Wittler RR, Yamada SM, Bass JW, Hamill R, Wiebe RA, Ascher DP: Penicillin tolerance and erythromycin resistance of group A beta-hemolytic streptococci in Hawaii and the Philippines. American Journal of Diseases of Children 1990, 144: 587–589.

    Google Scholar 

  24. Betriu C, Sanchez A, Gomez M, Cruceyra A, Picazo JJ: Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrobial Agents and Chemotherapy 1993, 37: 1717–1719.

    Google Scholar 

  25. Hsueh PR, Chen HM, Huang AH, Wu JJ: Decreased activity of erythromycin againstStreptococcus pyogenes in Taiwan. Antimicrobial Agents and Chemotherapy 1995, 39: 2239–2242.

    Google Scholar 

  26. Cornaglia G, Ligozzi M, Mazzariol A, Valentini M, Orefici G, Fontana R, and the Italian Surveillance Group for Antimicrobial Resistance: Rapid increase of resistance to erythromycin and clindamycin inStreptococcus pyogenes in Italy, 1993–1995. Emerging Infectious Diseases 1996, 2: 339–342.

    Google Scholar 

  27. Fujita J, Murono K, Yoshikawa M, Murai T: Decline of erythromycin resistance of group A streptococci in Japan. Pediatric Infectious Disease Journal 1994, 13: 1075–1078.

    Google Scholar 

  28. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P, and the Finnish Study Group for Antimicrobial Resistance: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New England Journal of Medicine 1997, 337: 441–446.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Microbiologia y Unidad de Epidemiologia Infecciosa, Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, Hospital NS Aránzazu, Apartado 477, 20080, San Sebastián, Spain

    E. Perez-Trallero, M. Urbieta, M. Montes, I. Ayestaran & J. M. Marimon

Authors
  1. E. Perez-Trallero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Urbieta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Montes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Ayestaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. M. Marimon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perez-Trallero, E., Urbieta, M., Montes, M. et al. Emergence ofStreptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur. J. Clin. Microbiol. Infect. Dis. 17, 25–31 (1998). https://doi.org/10.1007/BF01584359

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01584359

Keywords

Search

Navigation